| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 7.95e-10 | 11 | 91 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 3.41e-09 | 14 | 91 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 3.38e-08 | 21 | 91 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 6.83e-07 | 37 | 91 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 6.83e-07 | 37 | 91 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 7.84e-07 | 38 | 91 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 7.84e-07 | 38 | 91 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.61e-06 | 79 | 91 | 6 | GO:0004521 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.08e-06 | 46 | 91 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.93e-06 | 136 | 91 | 7 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 3.71e-05 | 136 | 91 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 6.90e-05 | 152 | 91 | 6 | GO:0016779 | |
| GeneOntologyMolecularFunction | nuclease activity | 8.99e-05 | 231 | 91 | 7 | GO:0004518 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.20e-04 | 417 | 91 | 9 | GO:0140098 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAM23 ERVK-8 ERVK-18 PSMB10 ERVK-7 ERVK-10 TMPRSS11A CAPN10 | 1.51e-04 | 430 | 91 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ERVK-6 AGO4 PTPRG DIS3L PTPRS ERVK-8 ERVK-7 VARS2 ERVK-10 ERVK-11 PLPPR1 PPM1A | 2.94e-04 | 807 | 91 | 12 | GO:0016788 |
| GeneOntologyMolecularFunction | chitinase activity | 3.04e-04 | 6 | 91 | 2 | GO:0004568 | |
| GeneOntologyMolecularFunction | chitin binding | 5.65e-04 | 8 | 91 | 2 | GO:0008061 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 TGM2 ADAM23 ERVK-8 ERVK-18 PSMB10 ERVK-7 ERVK-10 TMPRSS11A CAPN10 | 7.84e-04 | 654 | 91 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | integrin binding | 1.24e-03 | 175 | 91 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 2.69e-03 | 645 | 91 | 9 | GO:0140640 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.77e-09 | 13 | 90 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 2.09e-06 | 48 | 90 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | neuron projection development | TANC2 EPHB6 NMNAT2 PTPRG PTPRS NEUROD4 GLI3 FAT3 TET1 SMURF1 LAMA3 CRTC1 ACTL9 ITGA4 FLOT1 MUL1 CAPRIN1 SDK1 SEZ6 | 2.25e-06 | 1285 | 90 | 19 | GO:0031175 |
| GeneOntologyBiologicalProcess | cell morphogenesis | TANC2 EPHB6 FAT1 AGO4 PTPRS GLI3 FAT3 TET1 POC1B SMURF1 PSMB10 LAMA3 ACTL9 CFAP70 ITGA4 FLOT1 MUL1 CAPRIN1 | 3.34e-06 | 1194 | 90 | 18 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | EPHB6 FAT1 FAT2 ZAN PTPRG PTPRS GLI3 FAT3 ICAM3 LAMA3 ITGA4 VSIG10 ITGAL FLOT1 ITGAX SDK1 PCDH17 | 3.55e-06 | 1077 | 90 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 9.15e-06 | 313 | 90 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | neuron development | TANC2 EPHB6 NMNAT2 PTPRG PTPRS NEUROD4 GLI3 FAT3 TET1 SMURF1 LAMA3 CRTC1 ACTL9 ITGA4 FLOT1 MUL1 CAPRIN1 SDK1 SEZ6 | 1.46e-05 | 1463 | 90 | 19 | GO:0048666 |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.14e-05 | 83 | 90 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | TANC2 EPHB6 PTPRS GLI3 FAT3 TET1 SMURF1 LAMA3 ACTL9 ITGA4 FLOT1 CAPRIN1 | 9.71e-05 | 748 | 90 | 12 | GO:0048667 |
| GeneOntologyBiologicalProcess | dendrite development | 1.09e-04 | 335 | 90 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 1.70e-04 | 187 | 90 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | TANC2 EPHB6 PTPRS GLI3 TET1 SMURF1 LAMA3 ACTL9 ITGA4 FLOT1 MUL1 CAPRIN1 | 1.86e-04 | 802 | 90 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | spermatid differentiation | 1.89e-04 | 272 | 90 | 7 | GO:0048515 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | TANC2 EPHB6 PTPRS GLI3 TET1 SMURF1 LAMA3 ACTL9 ITGA4 FLOT1 MUL1 CAPRIN1 | 2.26e-04 | 819 | 90 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | TANC2 EPHB6 PTPRS GLI3 TET1 SMURF1 LAMA3 ACTL9 ITGA4 FLOT1 MUL1 CAPRIN1 | 2.44e-04 | 826 | 90 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | chitin catabolic process | 2.79e-04 | 6 | 90 | 2 | GO:0006032 | |
| GeneOntologyBiologicalProcess | chitin metabolic process | 2.79e-04 | 6 | 90 | 2 | GO:0006030 | |
| Domain | LamG | 1.64e-06 | 44 | 85 | 5 | SM00282 | |
| Domain | Laminin_G | 6.57e-06 | 58 | 85 | 5 | IPR001791 | |
| Domain | Integrin_alpha | 1.46e-05 | 11 | 85 | 3 | PF00357 | |
| Domain | LAM_G_DOMAIN | 2.62e-05 | 38 | 85 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 3.22e-05 | 40 | 85 | 4 | PF02210 | |
| Domain | Integrin_alpha_C_CS | 4.88e-05 | 16 | 85 | 3 | IPR018184 | |
| Domain | ConA-like_dom | 6.30e-05 | 219 | 85 | 7 | IPR013320 | |
| Domain | Integrin_alpha-2 | 7.07e-05 | 18 | 85 | 3 | IPR013649 | |
| Domain | Integrin_alpha2 | 7.07e-05 | 18 | 85 | 3 | PF08441 | |
| Domain | Integrin_alpha | 7.07e-05 | 18 | 85 | 3 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 7.07e-05 | 18 | 85 | 3 | PS00242 | |
| Domain | - | 7.28e-05 | 95 | 85 | 5 | 2.60.120.200 | |
| Domain | Int_alpha_beta-p | 8.36e-05 | 19 | 85 | 3 | IPR013519 | |
| Domain | Int_alpha | 8.36e-05 | 19 | 85 | 3 | SM00191 | |
| Domain | FG_GAP | 1.32e-04 | 22 | 85 | 3 | PS51470 | |
| Domain | FG-GAP | 1.72e-04 | 24 | 85 | 3 | PF01839 | |
| Domain | FG-GAP | 1.72e-04 | 24 | 85 | 3 | IPR013517 | |
| Domain | Integrin_dom | 1.95e-04 | 25 | 85 | 3 | IPR032695 | |
| Domain | Chitinase_insertion | 2.03e-04 | 5 | 85 | 2 | IPR029070 | |
| Domain | - | 2.03e-04 | 5 | 85 | 2 | 3.10.50.10 | |
| Domain | Glyco_hydro_18_chit_AS | 3.03e-04 | 6 | 85 | 2 | IPR001579 | |
| Domain | Glyco_hydro18_cat | 4.24e-04 | 7 | 85 | 2 | IPR001223 | |
| Domain | Glyco_hydro_18 | 4.24e-04 | 7 | 85 | 2 | PF00704 | |
| Domain | Chitinase_II | 4.24e-04 | 7 | 85 | 2 | IPR011583 | |
| Domain | Glyco_18 | 4.24e-04 | 7 | 85 | 2 | SM00636 | |
| Domain | CHITINASE_18 | 4.24e-04 | 7 | 85 | 2 | PS01095 | |
| Domain | EGF | 7.11e-04 | 235 | 85 | 6 | SM00181 | |
| Domain | fn3 | 8.66e-04 | 162 | 85 | 5 | PF00041 | |
| Domain | EGF-like_dom | 9.60e-04 | 249 | 85 | 6 | IPR000742 | |
| Domain | EGF_1 | 1.09e-03 | 255 | 85 | 6 | PS00022 | |
| Domain | EGF-like_CS | 1.22e-03 | 261 | 85 | 6 | IPR013032 | |
| Domain | EGF_2 | 1.32e-03 | 265 | 85 | 6 | PS01186 | |
| Domain | CUB | 1.44e-03 | 49 | 85 | 3 | PF00431 | |
| Domain | CUB | 1.53e-03 | 50 | 85 | 3 | SM00042 | |
| Domain | Cadherin_CS | 1.55e-03 | 109 | 85 | 4 | IPR020894 | |
| Domain | FN3 | 1.56e-03 | 185 | 85 | 5 | SM00060 | |
| Domain | - | 1.71e-03 | 52 | 85 | 3 | 2.60.120.290 | |
| Domain | Sushi | 1.71e-03 | 52 | 85 | 3 | PF00084 | |
| Domain | CADHERIN_1 | 1.76e-03 | 113 | 85 | 4 | PS00232 | |
| Domain | Cadherin | 1.76e-03 | 113 | 85 | 4 | PF00028 | |
| Domain | CUB | 1.81e-03 | 53 | 85 | 3 | PS01180 | |
| Domain | CADHERIN_2 | 1.82e-03 | 114 | 85 | 4 | PS50268 | |
| Domain | - | 1.82e-03 | 114 | 85 | 4 | 2.60.40.60 | |
| Domain | CA | 1.88e-03 | 115 | 85 | 4 | SM00112 | |
| Domain | CCP | 1.91e-03 | 54 | 85 | 3 | SM00032 | |
| Domain | Cadherin-like | 1.94e-03 | 116 | 85 | 4 | IPR015919 | |
| Domain | Cadherin | 2.07e-03 | 118 | 85 | 4 | IPR002126 | |
| Domain | - | 2.07e-03 | 15 | 85 | 2 | 3.30.70.960 | |
| Domain | SUSHI | 2.12e-03 | 56 | 85 | 3 | PS50923 | |
| Domain | FN3 | 2.15e-03 | 199 | 85 | 5 | PS50853 | |
| Domain | Sushi_SCR_CCP_dom | 2.23e-03 | 57 | 85 | 3 | IPR000436 | |
| Domain | CUB_dom | 2.23e-03 | 57 | 85 | 3 | IPR000859 | |
| Domain | FN3_dom | 2.66e-03 | 209 | 85 | 5 | IPR003961 | |
| Domain | EGF_3 | 4.38e-03 | 235 | 85 | 5 | PS50026 | |
| Domain | SEA | 4.46e-03 | 22 | 85 | 2 | PF01390 | |
| Domain | SEA | 4.87e-03 | 23 | 85 | 2 | PS50024 | |
| Domain | SEA_dom | 4.87e-03 | 23 | 85 | 2 | IPR000082 | |
| Domain | WD40 | 6.58e-03 | 259 | 85 | 5 | PF00400 | |
| Domain | WD40 | 7.57e-03 | 268 | 85 | 5 | SM00320 | |
| Domain | WD40_repeat | 8.04e-03 | 272 | 85 | 5 | IPR001680 | |
| Domain | WD_REPEATS_1 | 8.79e-03 | 278 | 85 | 5 | PS00678 | |
| Domain | WD_REPEATS_2 | 8.92e-03 | 279 | 85 | 5 | PS50082 | |
| Domain | WD_REPEATS_REGION | 8.92e-03 | 279 | 85 | 5 | PS50294 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.45e-04 | 26 | 56 | 3 | M47 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.75e-04 | 300 | 56 | 7 | M610 | |
| Pathway | PID_INTEGRIN2_PATHWAY | 2.02e-04 | 29 | 56 | 3 | M169 | |
| Pathway | WP_BENZENE_METABOLISM | 2.30e-04 | 6 | 56 | 2 | M39326 | |
| Pathway | REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION | 2.30e-04 | 6 | 56 | 2 | M27817 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 2.44e-04 | 77 | 56 | 4 | MM14670 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.56e-04 | 85 | 56 | 4 | M16441 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 4.36e-04 | 161 | 56 | 5 | M27871 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 5.22e-04 | 94 | 56 | 4 | M1041 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 5.48e-04 | 9 | 56 | 2 | MM1534 | |
| Pathway | BIOCARTA_LYMPHOCYTE_PATHWAY | 5.48e-04 | 9 | 56 | 2 | M22008 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3 | 5.66e-04 | 96 | 56 | 4 | M27784 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 7.11e-04 | 102 | 56 | 4 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 7.11e-04 | 102 | 56 | 4 | MM15830 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 8.33e-04 | 11 | 56 | 2 | MM1436 | |
| Pathway | BIOCARTA_MONOCYTE_PATHWAY | 8.33e-04 | 11 | 56 | 2 | M4956 | |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 1.73e-08 | 3 | 91 | 3 | 15744052 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.92e-08 | 4 | 91 | 3 | 10469592 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.73e-07 | 5 | 91 | 3 | 12629516 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.84e-07 | 94 | 91 | 6 | 21542922 | |
| Pubmed | 6.02e-07 | 7 | 91 | 3 | 16059920 | ||
| Pubmed | HERC5/IFI16/p53 signaling mediates breast cancer cell proliferation and migration. | 4.05e-06 | 90 | 91 | 5 | 35671810 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 20574620 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 28614626 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 20099501 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15240673 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 29233108 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 14657281 | ||
| Pubmed | Activation of leukocyte beta2 integrins by conversion from bent to extended conformations. | 6.77e-06 | 2 | 91 | 2 | 17045822 | |
| Pubmed | CD11c participates in triggering acute graft-versus-host disease during bone marrow transplantation. | 6.77e-06 | 2 | 91 | 2 | 33934334 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 28624692 | ||
| Pubmed | A genetic association study of CSMD1 and CSMD2 with cognitive function. | 6.77e-06 | 2 | 91 | 2 | 27890662 | |
| Pubmed | A mechanism for the upregulation of EGF receptor levels in glioblastomas. | 6.77e-06 | 2 | 91 | 2 | 23770238 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15622747 | ||
| Pubmed | The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. | 6.77e-06 | 2 | 91 | 2 | 21439553 | |
| Pubmed | Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients. | 6.77e-06 | 2 | 91 | 2 | 24408017 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15728350 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 15726833 | ||
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 6.77e-06 | 2 | 91 | 2 | 11672541 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 27977724 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 25294623 | ||
| Pubmed | 1.37e-05 | 18 | 91 | 3 | 18664271 | ||
| Pubmed | Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis. | 2.03e-05 | 3 | 91 | 2 | 21159721 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 12906867 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 17000779 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 20538957 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 16239568 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 11353828 | ||
| Pubmed | The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells. | 2.03e-05 | 3 | 91 | 2 | 20086179 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 3284962 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 19644363 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 18264102 | ||
| Pubmed | CD11a, CD11c, and CD18 gene polymorphisms and susceptibility to Behçet's disease in Koreans. | 2.03e-05 | 3 | 91 | 2 | 25155097 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 10516026 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 32500186 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 26079949 | ||
| Pubmed | Fundamentally different roles for LFA-1, Mac-1 and alpha4-integrin in neutrophil chemotaxis. | 2.03e-05 | 3 | 91 | 2 | 16249234 | |
| Pubmed | Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. | 2.03e-05 | 3 | 91 | 2 | 19008446 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 9971820 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 17913807 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23357382 | ||
| Pubmed | The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1. | 2.03e-05 | 3 | 91 | 2 | 11713248 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 15730520 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 15308572 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 23091001 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 16996813 | ||
| Pubmed | The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer. | 2.03e-05 | 3 | 91 | 2 | 29907679 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 20226308 | ||
| Pubmed | Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation. | 2.03e-05 | 3 | 91 | 2 | 15958209 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 9473377 | ||
| Pubmed | 2.32e-05 | 63 | 91 | 4 | 11572484 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 8020569 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 1448173 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 16037628 | ||
| Pubmed | CAP defines a second signalling pathway required for insulin-stimulated glucose transport. | 4.05e-05 | 4 | 91 | 2 | 11001060 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 10330002 | ||
| Pubmed | HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV. | 4.05e-05 | 4 | 91 | 2 | 21284901 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 25965880 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 36948698 | ||
| Pubmed | Specific phosphorylations transmit signals from leukocyte β2 to β1 integrins and regulate adhesion. | 4.05e-05 | 4 | 91 | 2 | 25278023 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 7983737 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 12163503 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 25231265 | ||
| Pubmed | Expression of beta 2 integrin (CD18) in embryonic mouse and chicken heart. | 4.05e-05 | 4 | 91 | 2 | 20069263 | |
| Pubmed | A self-sustained loop of inflammation-driven inhibition of beige adipogenesis in obesity. | 4.05e-05 | 4 | 91 | 2 | 28414311 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 15958383 | ||
| Pubmed | 4.68e-05 | 493 | 91 | 8 | 15368895 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 4.84e-05 | 27 | 91 | 3 | 31541017 | |
| Pubmed | Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins. | 6.74e-05 | 5 | 91 | 2 | 18239087 | |
| Pubmed | RGS10 restricts upregulation by chemokines of T cell adhesion mediated by α4β1 and αLβ2 integrins. | 6.74e-05 | 5 | 91 | 2 | 21705617 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 15210787 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 6.74e-05 | 5 | 91 | 2 | 11401426 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 24006483 | ||
| Pubmed | New paralogues and revised time line in the expansion of the vertebrate GH18 family. | 6.74e-05 | 5 | 91 | 2 | 23558346 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 1967280 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 12171996 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 21703542 | ||
| Pubmed | The cytosolic protein talin induces an intermediate affinity integrin alphaLbeta2. | 6.74e-05 | 5 | 91 | 2 | 17591777 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 37781399 | ||
| Pubmed | LFA-1 is critical for regulatory T cell homeostasis and function. | 6.74e-05 | 5 | 91 | 2 | 19428111 | |
| Pubmed | CD11c regulates hematopoietic stem and progenitor cells under stress. | 6.74e-05 | 5 | 91 | 2 | 33351105 | |
| Pubmed | Gammadelta T cells in EAE: early trafficking events and cytokine requirements. | 6.74e-05 | 5 | 91 | 2 | 19384874 | |
| Pubmed | Integrins take partners: cross-talk between integrins and other membrane receptors. | 1.01e-04 | 6 | 91 | 2 | 9789327 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 11857637 | ||
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 21460207 | ||
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 12208882 | ||
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 15585877 | ||
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 12528895 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.01e-04 | 6 | 91 | 2 | 26077710 | |
| Pubmed | Receptor protein tyrosine phosphatases are novel components of a polycystin complex. | 1.01e-04 | 6 | 91 | 2 | 21126580 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.41e-04 | 7 | 91 | 2 | 22510986 | |
| Pubmed | A point mutation in KINDLIN3 ablates activation of three integrin subfamilies in humans. | 1.41e-04 | 7 | 91 | 2 | 19234460 | |
| Pubmed | 1.41e-04 | 7 | 91 | 2 | 17548467 | ||
| Pubmed | 1.41e-04 | 7 | 91 | 2 | 15128873 | ||
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 1.41e-04 | 7 | 91 | 2 | 16946704 | |
| Pubmed | 1.88e-04 | 8 | 91 | 2 | 22908191 | ||
| GeneFamily | Cadherin related | 2.52e-05 | 17 | 62 | 3 | 24 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.02e-05 | 18 | 62 | 3 | 1160 | |
| GeneFamily | Fibronectin type III domain containing | 2.20e-04 | 160 | 62 | 5 | 555 | |
| GeneFamily | Chitinases | 2.40e-04 | 7 | 62 | 2 | 816 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 9.85e-04 | 57 | 62 | 3 | 1179 | |
| GeneFamily | WD repeat domain containing | 2.03e-03 | 262 | 62 | 5 | 362 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.33e-03 | 21 | 62 | 2 | 813 | |
| GeneFamily | Immunoglobulin like domain containing | 4.33e-03 | 193 | 62 | 4 | 594 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 190 | 85 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-06 | 190 | 85 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.09e-05 | 152 | 85 | 5 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-05 | 157 | 85 | 5 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 184 | 85 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.73e-05 | 184 | 85 | 5 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 184 | 85 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-05 | 184 | 85 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.73e-05 | 184 | 85 | 5 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.95e-05 | 187 | 85 | 5 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.18e-05 | 190 | 85 | 5 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-05 | 190 | 85 | 5 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.34e-05 | 192 | 85 | 5 | 6ace9a34ed264583042156ed61c2cb3504a331d2 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-05 | 192 | 85 | 5 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.42e-05 | 193 | 85 | 5 | 1e19f80c52833fb21a8d597a3ba2c4ff464c4559 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.51e-05 | 194 | 85 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 3.51e-05 | 194 | 85 | 5 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.60e-05 | 195 | 85 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.60e-05 | 195 | 85 | 5 | 4759018a7c016cb2e3df5696f1e5f912c7c9ee17 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.60e-05 | 195 | 85 | 5 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.78e-05 | 197 | 85 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.87e-05 | 198 | 85 | 5 | d02e1ff7f68dedaca1e367c7cade772e7b355f45 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.96e-05 | 199 | 85 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | 4be4527f351b701438a8bcb738229a06dbf8bc96 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | d3dc52e1f0040763888f951a7c047db4a329a653 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.34e-04 | 136 | 85 | 4 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.34e-04 | 136 | 85 | 4 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-04 | 146 | 85 | 4 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 147 | 85 | 4 | 64fa0753a3a79f492ef8acc6942bf90d379a983f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.05e-04 | 152 | 85 | 4 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 154 | 85 | 4 | 3211f003f4d1735c7cab9b6cc68af3e0bbfba35e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 154 | 85 | 4 | c0fe767fc9ab45b2dfa71171f2a673a4a8decbaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-04 | 154 | 85 | 4 | 4c2a7590791c2255b15dab82c3622f71f9ffd949 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 2.26e-04 | 156 | 85 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.32e-04 | 157 | 85 | 4 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 157 | 85 | 4 | 0ad242320ada7bcb9e29548d3050bf4fd3a07115 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 157 | 85 | 4 | fe4c9556806203e57522d1986754ebe5a20aa2de | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 160 | 85 | 4 | ac5d573c135d66d6adddd42dfddd9d3e01532172 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-D_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 160 | 85 | 4 | b81d218c20fe37921cf3c6c7db2da3bfd367230a | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.68e-04 | 163 | 85 | 4 | e393e5ff885a42b2b44e430d3d5a58f5e50eb732 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.68e-04 | 163 | 85 | 4 | 130c84bca3f72ab7d1a4fee2990c3d01600318ed | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 165 | 85 | 4 | fbd84f211ad645c91b9f45a0815391606f3206ac | |
| ToppCell | droplet-Spleen-nan-21m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-04 | 165 | 85 | 4 | 6fbdfacb49e627712ac999d40ae22dcb390edd3e | |
| ToppCell | NS-critical-d_0-4-Epithelial-unknown_epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.87e-04 | 166 | 85 | 4 | dd02bbe4af609c6348dc92417254f4740f2900a8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-04 | 168 | 85 | 4 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-04 | 168 | 85 | 4 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tnaive/CM_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.00e-04 | 168 | 85 | 4 | c51244b4bdbfd961e2725306aa9cb25dd66d58bd | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | 3f8aa6d2f9aa060ae1a0ea3eb47e794099fc2c2c | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | 26de495c7562e0740689d0f78e803698e3e793db | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 170 | 85 | 4 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 170 | 85 | 4 | 670027daec5a10dfa12246f1497b58db21d32a22 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.14e-04 | 170 | 85 | 4 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 171 | 85 | 4 | 7ca404539344e14dcd90c746c9122f713a7db78b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 171 | 85 | 4 | ab113c8e773b0af47a87aed50e96be3ba71c3c82 | |
| ToppCell | facs-Lung-24m-Epithelial-airway_epithelial-club_cell-club_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-04 | 171 | 85 | 4 | 8ed98f223143bd81d9819e9a420eb9cc81ee6c53 | |
| ToppCell | facs-Lung-24m-Epithelial-airway_epithelial-club_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-04 | 171 | 85 | 4 | bd339e482f09a3fa04b086029b94f45205b8a6c5 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 171 | 85 | 4 | 35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-04 | 172 | 85 | 4 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.28e-04 | 172 | 85 | 4 | f0b658baa4b41329c95a09387cc55ea046e2333f | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-04 | 173 | 85 | 4 | 7713716ec95932b2fac177ce4cfec027b4754cef | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.43e-04 | 174 | 85 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-04 | 175 | 85 | 4 | e4c9b3c6bde390a3892b112b673f93e118220eb9 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-04 | 175 | 85 | 4 | 4d36da7399c62c170cb603957b35a35efb2c3fbe | |
| ToppCell | LPS-IL1RA-Hematopoietic_Meg-Ery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.50e-04 | 175 | 85 | 4 | 2c39c1b112e873403ad2add8595cc256bf0b97a6 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-04 | 175 | 85 | 4 | 9d09636a103daa8f622c3dbfd1f1536aaec3b6bb | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.66e-04 | 177 | 85 | 4 | 59cf56c385c324f0844f20003d2b5049a2791e45 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-04 | 178 | 85 | 4 | a107dd98a07086ed0429116095ecda60c9dbef1e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.74e-04 | 178 | 85 | 4 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-04 | 179 | 85 | 4 | 7329b45376a9e9a4fe34d4aa0b33af6dda0a8e3b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-04 | 179 | 85 | 4 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-04 | 179 | 85 | 4 | 6e4740f99f66d3e9348fa5057cf1030454819aa8 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 3.82e-04 | 179 | 85 | 4 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Meg-Ery-Erythroid-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.82e-04 | 179 | 85 | 4 | ee60ac43fb62c09967a26bbcf9306ac5ea2bdc1e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.98e-04 | 181 | 85 | 4 | 154d5e586cab25155c6d06dfe6ae01203b88e0fb | |
| ToppCell | PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_NK/ILC-im_ILC2_(21)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.98e-04 | 181 | 85 | 4 | 1fa882ee66e6f835acf3f293fd24dc7f8b1eff99 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.98e-04 | 181 | 85 | 4 | 7f99002a6411117cc2361334c7c9228e20c574b4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 182 | 85 | 4 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | droplet-Tongue-nan-24m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 182 | 85 | 4 | 0f06309318c064f0ebdb12a46226b90032290137 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-04 | 182 | 85 | 4 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.06e-04 | 182 | 85 | 4 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cacng4_(Non-anterior_nuclei)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.14e-04 | 76 | 85 | 3 | 4afc8d0e79870c635a89dd8e7ca91ebfe482b4ab | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 183 | 85 | 4 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 183 | 85 | 4 | b153425ab0df1e5fa9b953e1f6d4e8e3dc6621b0 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 183 | 85 | 4 | ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-NK-Cycling_NK|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.15e-04 | 183 | 85 | 4 | 19652ca16989cb0be7d444cb5bf209b32d163bdb | |
| ToppCell | droplet-Lung-nan-21m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 183 | 85 | 4 | 19e7be1cfdd111bfb840532a6f7c780345dffccf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.15e-04 | 183 | 85 | 4 | 01c7f01498a9894920edf8243e41187cbdf90688 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.15e-04 | 183 | 85 | 4 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-04 | 183 | 85 | 4 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.23e-04 | 184 | 85 | 4 | 0efc757d9512d6a8fe8176e977a94e4494ed9778 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.23e-04 | 184 | 85 | 4 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.23e-04 | 184 | 85 | 4 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.23e-04 | 184 | 85 | 4 | 102105ae1a5ef6d42a43f6d9b00f12ed0690ddb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.23e-04 | 184 | 85 | 4 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.32e-04 | 185 | 85 | 4 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 4.32e-04 | 185 | 85 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| Computational | Adhesion molecules. | 8.92e-07 | 141 | 41 | 7 | MODULE_122 | |
| Drug | Bucladesine sodium salt [16980-89-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 8.43e-07 | 198 | 86 | 8 | 5886_UP | |
| Drug | 4-hydroxyquinoline 1-oxide | 1.03e-06 | 6 | 86 | 3 | CID000076437 | |
| Drug | Murametide | 2.87e-06 | 8 | 86 | 3 | CID000133276 | |
| Drug | NSC-86924 | 6.13e-06 | 10 | 86 | 3 | CID005357766 | |
| Drug | Bacitracin [1405-87-4]; Up 200; 2.8uM; HL60; HT_HG-U133A | 1.02e-05 | 198 | 86 | 7 | 3109_UP | |
| Drug | Ta 3 | 1.84e-05 | 14 | 86 | 3 | CID000027110 | |
| Drug | gpgG | 2.29e-05 | 15 | 86 | 3 | CID000485273 | |
| Disease | Colorectal Carcinoma | 3.09e-05 | 702 | 84 | 10 | C0009402 | |
| Disease | osteoarthritis biomarker measurement | 1.19e-04 | 6 | 84 | 2 | EFO_0005890 | |
| Disease | spontaneous preterm birth | 2.02e-04 | 101 | 84 | 4 | EFO_0006917 | |
| Disease | Glioblastoma Multiforme | 2.90e-04 | 111 | 84 | 4 | C1621958 | |
| Disease | nephritis (implicated_via_orthology) | 3.55e-04 | 10 | 84 | 2 | DOID:10952 (implicated_via_orthology) | |
| Disease | platelet-to-lymphocyte ratio | 6.03e-04 | 363 | 84 | 6 | EFO_0008446 | |
| Disease | hepcidin:transferrin saturation ratio | 8.21e-04 | 15 | 84 | 2 | EFO_0007902 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 9.36e-04 | 16 | 84 | 2 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 9.36e-04 | 16 | 84 | 2 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 9.36e-04 | 16 | 84 | 2 | cv:C1839071 | |
| Disease | Nonorganic psychosis | 1.02e-03 | 69 | 84 | 3 | C0349204 | |
| Disease | DDT metabolite measurement | 1.25e-03 | 74 | 84 | 3 | EFO_0007886 | |
| Disease | Glioblastoma | 1.51e-03 | 79 | 84 | 3 | C0017636 | |
| Disease | Crohn's disease | 1.64e-03 | 441 | 84 | 6 | EFO_0000384 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.80e-03 | 84 | 84 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Giant Cell Glioblastoma | 1.80e-03 | 84 | 84 | 3 | C0334588 | |
| Disease | prostate carcinoma (is_marker_for) | 1.95e-03 | 23 | 84 | 2 | DOID:10286 (is_marker_for) | |
| Disease | response to venlafaxine | 2.30e-03 | 25 | 84 | 2 | EFO_0006328 | |
| Disease | cerebellum cortex volume change measurement, age at assessment | 2.49e-03 | 26 | 84 | 2 | EFO_0008007, EFO_0021497 | |
| Disease | waist-hip ratio | CPAMD8 PTPRG ADAM23 PTPRS GLI3 POC1B CRTC1 PCNX1 ATP13A2 PURG | 2.51e-03 | 1226 | 84 | 10 | EFO_0004343 |
| Disease | visceral adipose tissue measurement | 2.53e-03 | 481 | 84 | 6 | EFO_0004765 | |
| Disease | Squamous cell carcinoma of esophagus | 2.55e-03 | 95 | 84 | 3 | C0279626 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLHSYVNSILIPGVG | 1131 | P23470 | |
| PVTYQVGYGHLSTLV | 671 | O60583 | |
| GVPHIVTQHTSFRGY | 366 | P20813 | |
| IGQLQGEIIPTSFYH | 671 | O75077 | |
| GEYHGTQAPQFLIST | 826 | Q96PZ7 | |
| VYHGTQVPQFLISTS | 821 | Q7Z408 | |
| VDTGHGVTYTVPVFQ | 196 | Q8TC94 | |
| IVGFPTYGHNFILSN | 261 | Q9BZP6 | |
| GVQGALLSHFIQPVY | 396 | Q96M93 | |
| TVGYPVTEAGHLQSL | 316 | Q9HC96 | |
| AGIQGTSRPSHYQVL | 756 | Q9HCK5 | |
| PNSAVQVTTGYQFHV | 436 | Q9NR90 | |
| LQTVVGTYHGSPDQS | 566 | Q14444 | |
| LGQNGTVSYSILPSH | 501 | O14917 | |
| GVQSLVLGAPRYQHT | 416 | P20702 | |
| TVYQTVAHPGIQGNL | 166 | P10746 | |
| LGPNGHVTYSIVTDT | 851 | Q14517 | |
| LSQLTHGVTQLGFYV | 14166 | Q8WXI7 | |
| VGHSFPITGIQYSVG | 386 | Q5XUX1 | |
| GQISATSHINIYQGP | 1346 | P10071 | |
| HIISPLQNGYFGLTV | 326 | Q96LI6 | |
| YVNPGTEAVSGHITI | 791 | Q16787 | |
| YPGGIHEVSVNQSLL | 146 | P35908 | |
| FHPNLVVGGTYSGQI | 351 | O14576 | |
| ATVHRILGQQVPYAT | 306 | P36222 | |
| YTRHGVPISVTGIAQ | 56 | O75955 | |
| GFVGFVTHYVLPQVR | 1301 | Q96RV3 | |
| LLQPVHVSVSSGYGS | 411 | P56645 | |
| QGSFQPTVVSLVHGY | 326 | Q8NBM8 | |
| ITYSLIGGNQLGHFT | 3356 | Q9NYQ8 | |
| VVPYVTTIFGGLHAG | 46 | Q96DT0 | |
| HTTGIPYNSQGQAIV | 731 | P63132 | |
| PSIQSFTDVIGHYIS | 161 | Q969V5 | |
| SQGYTPYVSHVGLQQ | 1941 | Q93074 | |
| RLIYTLQGHTGPVFT | 261 | Q8TC44 | |
| VSYGHIGVTILQIPS | 216 | Q8NGS3 | |
| TYGAIHNISGTIPGQ | 776 | O94886 | |
| HTTGIPYNSQGQAIV | 731 | P63135 | |
| HTTGIPYNSQGQAIV | 731 | Q9BXR3 | |
| GIGSPSVYHAVIVIF | 31 | Q96MC6 | |
| GFQVLEPQLTYSIGH | 181 | P15559 | |
| VGIPFFVNVTHNGTY | 446 | P32942 | |
| QYRITTVAHTEVGPG | 691 | Q13332 | |
| HTTGIPYNSQGQAIV | 731 | Q9QC07 | |
| YVGPHVLAVVTRTGF | 386 | Q9NQ11 | |
| IQSHGYEVFNIISPS | 16 | Q86XP6 | |
| SNYSGQTLQPIGVTH | 156 | Q6AI39 | |
| GYASHSGIPNIILTV | 551 | Q6UUV9 | |
| HIITVGTGQGSLLFY | 351 | Q5T6F0 | |
| LHPGLHYGVSQTTTI | 881 | Q5T0N1 | |
| STSVYPNGHFVRVLG | 401 | Q8TF46 | |
| IQGGIHGTVPLTAYV | 1261 | Q8IZJ3 | |
| VISYDFPVGGHITAV | 586 | Q8TDW7 | |
| NGIFTINPYSGVITT | 1711 | Q8TDW7 | |
| FIGLNSVHCVQGSYP | 556 | Q8TF76 | |
| LTVHGFVNPTSFVYG | 776 | P13612 | |
| TVTVLLQYPGEVHGS | 211 | Q9UQ10 | |
| TDPVTLNVGGHLYTT | 11 | Q8NC69 | |
| HIITVGTGQGSLLFY | 361 | Q5VU92 | |
| GYVTADGNILQTIPH | 306 | P22681 | |
| QLHPVITTQSAGGVY | 2181 | Q7Z5N4 | |
| FTFTVNNVPSGHILV | 826 | Q6ZTR5 | |
| YFGHSLGQEQTIVLP | 211 | Q9UJV8 | |
| GIPYHIVNIVSGSLN | 356 | P49591 | |
| LITDYAVQPHVGTGA | 376 | Q5ST30 | |
| SFLQSVHGRPYLTQG | 21 | Q765I0 | |
| PVGVGQRLDTYTHVN | 251 | P41225 | |
| DGYTPGHILQAIQSV | 731 | A6NCM1 | |
| TVTQLSPGHIYGFQV | 546 | O15197 | |
| AVHSSTVIPTGAYGQ | 1621 | Q9HCD6 | |
| YHFVPGTTAVLTQTV | 241 | P40306 | |
| SQVQTIHGTQIGSYF | 446 | P20701 | |
| FVNAGQVVTGHLTPY | 141 | Q8TBJ4 | |
| VQGQVYFLHTQTGVS | 246 | Q9HCE7 | |
| NVVTVSPYALTHVAG | 2116 | Q8NFU7 | |
| LGIPTRVVTNYNSAH | 291 | P21980 | |
| GSTAVGVLISPQHTY | 126 | P35813 | |
| GVLISPQHTYFINCG | 131 | P35813 | |
| LFPGTYGNSVLVSIV | 71 | Q9NYW1 | |
| HTTGIPYNSQGQAIV | 731 | P10266 | |
| HTTGIPYNSQGQAIV | 731 | P63133 | |
| LGHQTFVSQPGYVGL | 121 | P30530 | |
| HTTGIPYNSQGQAIV | 731 | Q9UQG0 | |
| PGTSVLGYQQGFVIH | 686 | Q53EL9 | |
| STFGYVHGVSGPVVT | 16 | P38606 | |
| NQPITFHGATVVQYI | 126 | Q8WUU8 | |
| SGPYQIEVHIVATGT | 121 | Q8N0Z9 | |
| QGYEGFVAVHSLPTV | 621 | Q8WU66 | |
| YVGLLSNPQAHVSGV | 506 | Q6NUS6 | |
| HSGQTLYEQVVFTNP | 541 | Q9UP52 | |
| QPNLTVHITGFGALY | 301 | Q6ZMR5 | |
| SHLVEVTVPSSYGGQ | 1661 | Q9Y493 | |
| YPHHGIGTQLNTVFT | 316 | Q9HD90 | |
| FIVIGGIVSPVHDSY | 41 | Q9BZQ4 |